z-logo
open-access-imgOpen Access
Prosthetic Valve Endocarditis After Transcatheter Aortic Valve Implantation
Author(s) -
Niels Thue Olsen,
Ole De Backer,
Hans Gustav Hørsted Thyregod,
Niels Vejlstrup,
Henning Bundgaard,
Lars Søndergaard,
Nikolaj Ihlemann
Publication year - 2015
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.114.001939
Subject(s) - medicine , hazard ratio , surgery , interquartile range , confidence interval , endocarditis , stenosis , aortic valve , complication , prosthesis , cardiology , aortic valve stenosis
Transcatheter aortic valve implantation (TAVI) is an advancing mode of treatment for inoperable or high-risk patients with aortic stenosis. Prosthetic valve endocarditis (PVE) after TAVI is a serious complication, but only limited data exist on its incidence, outcome, and procedural risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom